Glaxosmithkline Share News (GSK)

One Dead After Explosion At GlaxoSmithKline Site In Belgium

London pre-open: Europe likely to follow the US lower

(ShareCast News) - City sources predict the FTSE 100 will open 25 points lower than Monday's close of 6,688.62. Overnight markets were mixed with the US down and Asia up, but Europe has followed the US, London Capital Group night editor Jonathan Sudaria said. "Gains in Asia, and in particular

GSK re-hires China government relations exec linked to whistleblower probe

SHANGHAI, Aug 3 (Reuters) - Britain's GlaxoSmithKline PLC said on Monday it had re-hired Vivian Shi, a former Chinese government affairs executive at the firm who was the focus of an internal probe into information leaks alleging bribery at the company's China unit. GSK was fined $489 mill

After Merck success, work goes on with other Ebola vaccines

By Ben Hirschler LONDON, July 31 (Reuters) - Scientists and drug companies will continue to research the potential of alternative Ebola vaccines, despite a shot from Merck and NewLink Genetics proving 100 percent effective in a trial in Guinea. Experts said on Friday different kinds

BROKER RATINGS SUMMARY: Deutsche And Citi Go Opposite Ways On Indivior

PRESS: Glaxo Investigating Corruption Allegations In Romania - Reuters

GlaxoSmithKline sees staged roll-out of malaria vaccine

LONDON, July 29 (Reuters) - The world's first malaria vaccine, which won a green light last week from European drugs regulators, will be rolled out gradually in Africa, its maker said on Wednesday. "We believe that there should be a thoughtful, staged roll-out of this vaccine, particularly

LONDON MARKET CLOSE: Shares Gain As Investors Await Fed Statement

FTSE 100 movers: GSK and Hikma lead blue chips higher

(ShareCast News) - The FTSE 100 index built an early lead on Wednesday and stayed in positive territory thanks to forecast-busting results from several heavyweights in the pharma, tobacco and banking sectors. London's blue chip index was up 0.57% to 6,592.54 at 1435 BST. Top of the leaderboard mid-

2nd UPDATE: GlaxoSmithKline On Track For 2015 And Confident For 2016

GlaxoSmithKline rallies as second-quarter earnings beat estimates

(ShareCast News) - Shares in GlaxoSmithKline rallied after the pharmaceutical company posted better-than-expected second-quarter earnings and operating profits, and said it expects to see a significant recovery in core earnings per share next year. Sales for the period were up 6% at £5.9bn, while co

UPDATE 2-GSK flags up pipeline as HIV drugs help it beat profit forecasts

* HIV sales help offset margin slide post Novartis deal * Q2 core EPS 17.3 pence vs consensus 16.7p * Q2 sales 5.9 billion pounds, in line with consensus * GSK says has around 40 new drugs and vaccines in Phase II/III * Shares up more than 3 percent on earnings beat (Add

UPDATE: GlaxoSmithKline On Track For 2015, Confident In 2016 Outlook

GlaxoSmithKline On Track For Guidance, Confident In 2016 Outlook

GlaxoSmithKline Q2 beats despite Advair hit, lower margins

LONDON, July 29 (Reuters) - A further slide in sales of lung drug Advair and lower profit margins following a business overhaul hit GlaxoSmithKline in the second quarter, although core earnings per share fell by a less-than-expected 9 percent. The drugmaker recently sold its marketed cancer